Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gonocea Biotech

- PMLiVE

GSK’s pivotal TB vaccine could prevent millions of deaths

Key study took place in TB-endemic regions, testing 3,500 participants

- PMLiVE

Genital herpes vaccine candidate heads for human studies

Follows decades of failed R&D into sexually-transmitted infection

- PMLiVE

HIV meeting hears progress towards vaccine and cure

Hope for global treatment

- PMLiVE

Merck says drug for CMV in transplant patients hits targets

Letermovir on course for fast-track 2017 filing and head start in prospective $350m market

- PMLiVE

Aduro pancreatic cancer vaccine trial disappoints

Immunotherapy combination fails to improve overall survival over existing treatments

- PMLiVE

Ebola vaccine completely effective, say researchers

Merck earns plaudits for ‘game-changing’ vaccine

EU flag

EMA launches review of cervical cancer vaccine safety

Regulator assessing possible side effects of pain and arrhythmia in girls using the treatments

- PMLiVE

Vical’s genital herpes vaccine flunks trial

The drug did however reduce the emergence of genital lesions in some patients

- PMLiVE

UK to pay for GSK’s MenB vaccine after year’s delay

British firm says the deal offers ‘fair value’ to the NHS

- PMLiVE

Pricing pressures preventing UK access to MenB vaccine

GlaxoSmithKline’s Bexsero will need a dramatic price cut to gain NHS entry

- PMLiVE

Pfizer buys majority stake in Redvax

Will see the US pharma company gain access to early stage vaccine projects

Sanofi reception

Sanofi to work with Immune Design on herpes vaccine

Both companies have separate vaccines in development but will pool resources

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links